Pricey prostate cancer drug's makers targeted by Congress
Lawmakers again are targeting the pharmaceutical industry over sky-high prescription drug prices, a hot issue this year in Washington and on the campaign trail that's been dragging down stock prices of many drugmakers.
Mar 29, 2016
0
1